BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2514 related articles for article (PubMed ID: 17660238)

  • 21. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats.
    Giunta S; Castorina A; Bucolo C; Magro G; Drago F; D'Agata V
    Peptides; 2012 Sep; 37(1):32-9. PubMed ID: 22721946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
    Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
    J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary adenylyl cyclase-activating polypeptide controls the proliferation of retinal progenitor cells through downregulation of cyclin D1.
    Njaine B; Martins RA; Santiago MF; Linden R; Silveira MS
    Eur J Neurosci; 2010 Aug; 32(3):311-21. PubMed ID: 20646049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
    Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
    Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on mouse preantral follicle development in vitro.
    Cecconi S; Rossi G; Barberi M; Scaldaferri L; Canipari R
    Endocrinology; 2004 Apr; 145(4):2071-9. PubMed ID: 14701671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotropin-dependent regulation of bovine pituitary adenylate cyclase-activating polypeptide in ovarian follicles prior to ovulation.
    Sayasith K; Brown KA; Sirois J
    Reproduction; 2007 Feb; 133(2):441-53. PubMed ID: 17307912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
    Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
    Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and functional activity of PACAP and its receptors on cumulus cells: effects on oocyte maturation.
    Barberi M; Di Paolo V; Latini S; Guglielmo MC; Cecconi S; Canipari R
    Mol Cell Endocrinol; 2013 Aug; 375(1-2):79-88. PubMed ID: 23684890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ageing and the diurnal expression of mRNAs for vasoactive intestinal peptide and for the VPAC2 and PAC1 receptors in the suprachiasmatic nucleus of male rats.
    Kalló I; Kalamatianos T; Piggins HD; Coen CW
    J Neuroendocrinol; 2004 Sep; 16(9):758-66. PubMed ID: 15344914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
    Apostolakis EM; Riherd DN; O'Malley BW
    Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice.
    Girard BA; Lelievre V; Braas KM; Razinia T; Vizzard MA; Ioffe Y; El Meskini R; Ronnett GV; Waschek JA; May V
    J Neurochem; 2006 Oct; 99(2):499-513. PubMed ID: 17029602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
    Delgado M; Reduta A; Sharma V; Ganea D
    J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) in the cochlea: evidence for specific transcript expression of PAC1-R splice variants in rat microdissected cochlear subfractions.
    Abu-Hamdan MD; Drescher MJ; Ramakrishnan NA; Khan KM; Toma VS; Hatfield JS; Drescher DG
    Neuroscience; 2006 Jun; 140(1):147-61. PubMed ID: 16626868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioprotective role of the VIP signaling system.
    Dvoráková MC
    Drug News Perspect; 2005; 18(6):387-91. PubMed ID: 16247516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors in the zebrafish ovary: evidence for potentially dual roles of PACAP in controlling final oocyte maturation.
    Zhou R; Tsang AH; Lau SW; Ge W
    Biol Reprod; 2011 Sep; 85(3):615-25. PubMed ID: 21636738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 126.